Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psychiatry Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psychiatry Other
    FDA Requests Boxed Warnings on Conventional Antipsychotic Drugs - (DGNews)
    Pramlintide-Related Improvements in Diabetes Benefit Patients' Psyche: Presented at ADA - (DGDispatch)
    Health Canada Approves New Treatment for Bipolar Mania - (DGNews)
    Report Confirms Increased Risk of Smoking, Substance Abuse in Bipolar Adolescents - (DGNews)
    Short-Term Antipsychotics in Older Adults With Dementia Associated With Serious Adverse Events - (DGNews)

    News archive

     Recent webcasts/CME - Psychiatry Other
    • Dementia in Hispanic Americans: The Reasons Behind the Risk
    • Prevalence and Associated Factors for Suicidal Ideation and Behaviors in Obsessive-Compulsive Disorder
      Delirium Update
      The Pharmacist's Role in Breaking the Cycle of PMDD
      Understanding Autism: The Role of the Pharmacist in the Management of Autism

      Webcasts/CME archive

       Recent cases - Psychiatry Other
        Factitious Lymphoedema as a Psychiatric Condition Mimicking Reflex Sympathetic Dystrophy: A Case Report
        Topiramate-Induced Psychosis in Two Members of the One Family: A Case Report
        Childhood Autism in a 13 Year Old Boy with Oculocutaneous Albinism: A Case Report
        Unexpected Depletion in Plasma Choline and Phosphatidylcholine Concentrations in a Pregnant Woman with Bipolar Affective Disorder Being Treated with Lithuim, Haloperidol and Benztropine: A Case Report
        Recognizing Thyrotoxicosis in a Patient with Bipolar Mania: A Case Report

        Cases archive
          




        my personal edition > psychiatry other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Donepezil Beneficial For Severe Dementia and Neuropsychiatric Symptoms in Elderly: Presented at CPA

        By Donalee Moulton

        HALIFAX, CANADA -- November 5, 2003 -- Donepezil appears to be beneficial to nursing-home patients with severe dementia who have clinically significant neuropsychiatric symptoms, according to the results of a recent study presented here November 2nd during the 53rd Annual Meeting of the Canadian Psychiatric Association.

        Francois Rousseau, MD, psychiatrist, Robert-Giffard Hospital and Laval University, Quebec City, Canada, presented results of an open-label pilot study with 24 subjects. All participants had clinically significant neuropsychiatric symptoms not currently being controlled by medication.

        Over a period of 24 weeks, participants received either 5 mg/day or 10 mg/day of donepezil. They were assessed every 4 weeks for the first 3 months, then every 6 weeks until the end of the study. The primary instrument used to measure changes was the Neuropsychiatric Inventory (Nursing Home version), which contains 12 items designed to assess behavioural disturbances in demented individuals, and includes a caregiver component.

        The study results indicate that, at baseline, 75% of participants were classified as either a 6D or 6E on the Functional Assessment of Staging Scale. In spite of the advanced stages of dementia, however, cognition and function were maintained in participants over the course of the study, said Dr. Rousseau.

        Statistically significant improvements were noted on the Neuropsychiatric Inventory at each assessment point, beginning in week 8 and moving forward to the final week of the study. Eleven of the 12 subscales for caregivers indicated results favourable to the use of donepezil in this study population. Scores also improved significantly on key measures, including anxiety, elation, irritability and agitation/aggression.

        "These results are in line with previous studies conducted among mild-to-moderate and moderate-to-severe subjects," noted Dr. Rousseau. "Maintenance of functioning in this [advanced dementia] group represents a positive treatment outcome," he concluded.


        [Study Title: Donepezil Treatment of Clinically Significant Psychiatric Symptoms in Nursing Home Patients Suffering from Dementia. Abstract P1-21]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send